As lightning strikes across the world, some scientists wonder if it plays a hidden role in Earth’s energy balance, hinting ...

Rumors and theories suggest powerful figures may be preparing for Earth’s collapse with secret space plans raising urgent ...

Ginger also understands what it means to be a visible figure in the body-diverse community. Should she win All Stars 10, ...

I hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...

NVO is expanding into rare blood disorders like hemophilia to ease reliance on GLP-1 drugs Ozempic and Wegovy.

Wall Street's smartest money has quietly amassed over $150 million in bullish positions, with Goldman Sachs eliminating all ...

Both well-established and small, clinical-stage pharma companies are investing heavily to be able to someday compete with ...

MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...

They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, Wegovy or Zepbound are said to be a weight-loss game changer and could drive ...

UBS remains bullish on Eli Lilly’s future thanks to surging demand for its obesity and diabetes treatments. UBS predicts Zepbound sales could exceed market expectations by roughly 15%. Meanwhile, ...